search
for
 About Bioline  All Journals  Testimonials  Membership  News


Tropical Journal of Pharmaceutical Research
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
ISSN: 1596-5996
EISSN: 1596-5996
Vol. 13, No. 3, 2014, pp. 429-435
Bioline Code: pr14063
Full paper language: English
Document type: Research Article
Document available free of charge

Tropical Journal of Pharmaceutical Research, Vol. 13, No. 3, 2014, pp. 429-435

 en Factors Associated with Treatment Response to Antidiabetic Agents in Compliant Type 2 Diabetes Mellitus Patients: A Brief Summary of 5-Year Data
Huri, Hasniza Zaman & Xiang, Lee Tze

Abstract

Purpose: To evaluate the response to diabetic medications and factors influencing drug response in compliant type 2 diabetes mellitus (T2DM) patients.
Methods: A cross-sectional, retrospective study was performed on 100 T2DM patients at the University Malaya Medical Centre (UMMC) who were prescribed with at least one antidiabetic medication between January 2007 and December 2011.
Results: Using data from their medical records, it was determined that both fasting plasma glucose (FPG) and glycated hemoglobin (A1c) levels among all subjects were lower than baseline values. However, the reductions were not significant (p = 0.239 and p = 0.093). Factors that were significantly associated with the response to diabetic medications, include hypertension (p = 0.011), sulfonylureas (p = 0.041), beta-blockers (p = 0.005), and baseline A1c levels (p < 0.001).
Conclusion: Treatment of T2DM can be further optimized to ensure that diabetes is well-controlled.

Keywords
Treatment response; Antidiabetics; Type 2 Diabetes Mellitus; Hypertension; Beta-blocker

 
© Copyright 2014 - Tropical Journal of Pharmaceutical Research
Alternative site location: http://www.tjpr.org

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil